Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HSCSNASDAQ:ICUNASDAQ:INBSNASDAQ:LFWD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSCSHeart Test Laboratories$3.60-3.0%$3.49$2.36▼$5.77$3.89M2.56121,982 shs25,461 shsICUSeaStar Medical$1.24$1.25$1.11▼$13.85$12.84M-0.89264,164 shs95,848 shsINBSIntelligent Bio Solutions$1.90-4.0%$1.35$1.00▼$3.00$13.13M4.58556,542 shs148,720 shsLFWDReWalk Robotics$1.14-5.0%$1.34$1.13▼$4.77$12.55M0.16692,434 shs136,106 shs20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSCSHeart Test Laboratories+3.34%-1.85%+6.92%+23.05%-32.30%ICUSeaStar Medical-0.80%+2.48%-2.36%-34.32%-70.33%INBSIntelligent Bio Solutions+8.20%+25.32%+59.04%-6.60%0.00%LFWDReWalk Robotics-1.64%-2.44%-11.76%-25.00%-74.19%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHSCSHeart Test Laboratories2.6968 of 5 stars3.53.00.00.03.00.01.3ICUSeaStar Medical0.6812 of 5 stars0.03.00.00.02.71.70.0INBSIntelligent Bio Solutions0.3933 of 5 stars0.02.00.00.02.80.00.6LFWDReWalk Robotics2.8371 of 5 stars3.53.00.00.03.60.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHSCSHeart Test Laboratories 3.00Buy$13.00261.11% UpsideICUSeaStar Medical 0.00N/AN/AN/AINBSIntelligent Bio Solutions 0.00N/AN/AN/ALFWDReWalk Robotics 3.00Buy$9.00689.47% UpsideCurrent Analyst Ratings BreakdownLatest HSCS, LFWD, ICU, and INBS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/18/2025HSCSHeart Test LaboratoriesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $14.00(Data available from 6/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHSCSHeart Test Laboratories$14.70K264.73N/AN/A$11.16 per share0.32ICUSeaStar Medical$428K30.00N/AN/A($6.29) per share-0.20INBSIntelligent Bio Solutions$2.94M4.47N/AN/A$0.80 per share2.38LFWDReWalk Robotics$25.41M0.49N/AN/A$5.42 per share0.21Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHSCSHeart Test Laboratories-$6.61M-$7.48N/AN/AN/AN/A-117.76%-84.09%8/4/2025 (Estimated)ICUSeaStar Medical-$26.23M-$3.47N/A∞N/AN/AN/A-627.49%8/11/2025 (Estimated)INBSIntelligent Bio Solutions-$10.16MN/A0.005.43N/A-323.79%-146.03%-83.62%N/ALFWDReWalk Robotics-$22.13M-$3.04N/AN/AN/A-77.21%-43.02%-31.53%8/13/2025 (Estimated)Latest HSCS, LFWD, ICU, and INBS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025LFWDReWalk Robotics-$0.33-$0.46-$0.13-$0.46$5.84 million$5.03 million5/14/2025Q1 2025ICUSeaStar Medical-$0.52-$0.44+$0.08-$0.44$0.15 million$0.29 million3/27/2025Q4 2024ICUSeaStar Medical-$0.89-$0.90-$0.01-$0.90$0.15 million$0.07 million3/13/2025Q3 2025HSCSHeart Test Laboratories-$2.53-$2.5722-$0.0422-$2.57N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHSCSHeart Test LaboratoriesN/AN/AN/AN/AN/AICUSeaStar MedicalN/AN/AN/AN/AN/AINBSIntelligent Bio SolutionsN/AN/AN/AN/AN/ALFWDReWalk RoboticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHSCSHeart Test Laboratories0.011.721.52ICUSeaStar MedicalN/A0.540.54INBSIntelligent Bio SolutionsN/A0.920.76LFWDReWalk RoboticsN/A2.651.90Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHSCSHeart Test Laboratories17.24%ICUSeaStar Medical1.69%INBSIntelligent Bio Solutions32.97%LFWDReWalk Robotics26.76%Insider OwnershipCompanyInsider OwnershipHSCSHeart Test Laboratories1.80%ICUSeaStar Medical1.30%INBSIntelligent Bio Solutions1.54%LFWDReWalk Robotics2.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHSCSHeart Test Laboratories101.08 million962,000Not OptionableICUSeaStar Medical210.36 million4.37 millionNot OptionableINBSIntelligent Bio Solutions106.91 million5.26 millionNot OptionableLFWDReWalk Robotics6011.01 million10.36 millionOptionableHSCS, LFWD, ICU, and INBS HeadlinesRecent News About These CompaniesLifeward Appoints Mark Grant As New CEO: Retail Sentiment DipsMay 20, 2025 | msn.comLifeward Ltd.: Lifeward Names Mark Grant as New CEOMay 19, 2025 | finanznachrichten.deLongtime Medtronic leader is the new Lifeward CEOMay 19, 2025 | massdevice.comLifeward Names Mark Grant as New CEOMay 19, 2025 | globenewswire.comLifeward to Present at Sidoti Virtual Investor Conference on May 21May 19, 2025 | globenewswire.comLifeward reaffirms $28M–$30M 2025 revenue guidance as pipeline expands 70% and cost controls tightenMay 15, 2025 | msn.comLifeward (LFWD) Reports Q1 Loss, Lags Revenue EstimatesMay 15, 2025 | zacks.comLifeward Ltd. Reports First Quarter 2025 Financial ResultsMay 15, 2025 | globenewswire.comLifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and ExoskeletonsMay 8, 2025 | globenewswire.comLifeward to Report First Quarter 2025 Financial Results on May 15, 2025May 7, 2025 | globenewswire.comFirst Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal ExoskeletonApril 29, 2025 | globenewswire.comLifeward says Israeli soldier walks again with ReWalk Personal ExoskeletonApril 24, 2025 | markets.businessinsider.comParalyzed Israeli Soldier Walks Again with Use of the ReWalk Personal ExoskeletonApril 24, 2025 | globenewswire.comLFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7April 16, 2025 | zacks.comLifeward launches next-gen ReWalk 7 personal exoskeleton in the U.S.April 15, 2025 | massdevice.comLifeward launches sales of ReWalk 7 Personal Exoskeleton in the U.S.April 15, 2025 | markets.businessinsider.comLifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. MarketApril 15, 2025 | globenewswire.comLake Street Reaffirms Their Buy Rating on Lifeward (LFWD)April 15, 2025 | markets.businessinsider.comLifeward Ltd. (LFWD): Among the Penny Stocks With Huge Upside Potential According to AnalystsMarch 23, 2025 | msn.comLifeward Stock Falls Despite FDA Clearance of ReWalk 7 ExoskeletonMarch 17, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeAnalysts Think These Stocks Could More Than Double in ValueBy Nathan Reiff | May 23, 2025View Analysts Think These Stocks Could More Than Double in ValueIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s Watching3 Industrials Stocks Standing Out for Growth and Analyst OptimismBy Nathan Reiff | June 4, 2025View 3 Industrials Stocks Standing Out for Growth and Analyst OptimismWhich U.S. Towns See Economic Change First? [2025 Survey]By MarketBeat Staff | June 9, 2025View Which U.S. Towns See Economic Change First? [2025 Survey]HSCS, LFWD, ICU, and INBS Company DescriptionsHeart Test Laboratories NASDAQ:HSCS$3.60 -0.11 (-2.96%) As of 04:00 PM EasternHeart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.SeaStar Medical NASDAQ:ICU$1.24 0.00 (0.00%) As of 04:00 PM EasternSeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.Intelligent Bio Solutions NASDAQ:INBS$1.90 -0.08 (-4.04%) As of 04:00 PM EasternIntelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.ReWalk Robotics NASDAQ:LFWD$1.14 -0.06 (-5.00%) As of 04:00 PM EasternReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ignore the Noise—Samsara Stock Is Still a Strong Buy Oracle’s Cloud Boom Is Just Getting Started Netflix Sets New Highs—Price Targets Keep Climbing IonQ’s $1B Acquisition and Drug Discovery Leap With NVIDIA Alibaba’s Dip Is a Gift—Here’s the Price That Matters Betting on Disruption: Is Lemonade the Future of Insurance? Starbucks Stock: Culture Fix May Be Key to Long-Term Growth GameStop Turns a Profit, But Core Business Keeps Shrinking Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
